Therapeutic Pipelines

Adnexus Biotechnologies is a biotechnology company, with a specialized focus on diagnosing, preventing, and treating infectious diseases. Our approach is multi-faceted, leveraging three complementary platforms that work in synergy to generate our clinical products. Each platform is a testament to our commitment to innovation and excellence, contributing to a robust pipeline of solutions that are set to redefine healthcare. At Adnexus, we’re not just developing drugs – we’re shaping the future of medicine.

Antiviral Therapeutics Platform
HIV CAPSID INHIBITOR
Artificial Intelligence Platform

has a wholly-owned AI platform that drives:

Early Drug Discovery & Development and
Builds Intellectual Property Portfolio
Human Monoclonal Antibody Platform

that produces multiple antibodies against infectious diseases

Anti-HIV monoclonal antibodies (mAbs).-Monoclonal antibodies directed against the HIV virus.
Anti-SARS-CoV-2 monoclonal antibodies (mAbs)-Monoclonal antibodies directed against the Coronavirus (all variants).

Get in touch

For more information on our services and research projects, please click here to submit an enquiry.

Contact us